Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Silence Therapeutics (SLN) Asset Utilization Ratio (2024 - 2025)

Silence Therapeutics (SLN) has disclosed Asset Utilization Ratio for 2 consecutive years, with 0.0 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 98.58% to 0.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0 through Dec 2025, down 98.58% year-over-year, with the annual reading at 0.0 for FY2025, 98.75% down from the prior year.
  • Asset Utilization Ratio hit 0.0 in Q4 2025 for Silence Therapeutics, down from 0.17 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.27 in Q4 2024 to a low of 0.0 in Q4 2025.